1Suppliers
0Customers
1Debt Items
0Related Chains
Instil Bio, Inc. Suppliers
| Ticker | Name | Confidence | Evidence |
| IMMUNEONCO-BIOPHARMACEUTICALS-SHANGHAI-INC |
IMMUNEONCO-BIOPHARMACEUTICALS-SHANGHAI-INC |
92%
|
As part of the IO Collaboration Agreement, Axion Bio made a $ 10.0 million upfront payment to ImmuneOnco during the year ended December 31, 2024. |
Instil Bio, Inc. Customers
No clients on recordNo downstream customers found in our database for Instil Bio, Inc..
Instil Bio, Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
| TIL-DEBT-12984 |
Xbrl Convertible |
90%
|
xbrl convertible detail from xbrl 2021-12-31. |
Instil Bio, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Instil Bio, Inc..
Instil Bio, Inc. Ownership
| Holder | Name | Confidence | Evidence |
| TIL-OWNER-BML-CAPITAL-MANAGEMENT-LLC |
BML Capital Management, LLC |
90%
|
13F overlay lists BML Capital Management, LLC as top holder; 31 tracked holders. |
Instil Bio, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.